Correlation between phase 2 clinical trial design and subsequent phase 3 outcome.
Annette E. Hay
No relevant relationships to disclose
Jose Gerard Monzon
No relevant relationships to disclose
Gail T McDonald
No relevant relationships to disclose
Joseph L Pater
No relevant relationships to disclose
Ralph M. Meyer
No relevant relationships to disclose
Eric Xueyu Chen
No relevant relationships to disclose
Bingshu E. Chen
No relevant relationships to disclose
Janet Dancey
No relevant relationships to disclose